CLOVER Gene Editing Technology Licensed to Hudson River Biotechnology
CLOVER Gene Editing Technology Licensed to Hudson River Biotechnology LEXINGTON, KY – Demeetra AgBio, a pioneer in precision gene editing technologies for commercially applicable systems, is proud to announce that Hudson River Biotechnology has officially in-licensed our cutting-edge CLOVER genome editing tool. This strategic partnership marks a significant milestone in advancing agricultural biotechnology and sustainable crop production. The…55
Demeetra to Present Preclinical Data on Investigational Cannabinoid Derivatives at the 2025 Crohn’s and Colitis Congress
Demeetra to Present Preclinical Data on Investigational Cannabinoid Derivatives at the 2025 Crohn’s and Colitis Congress Novel non-natural small molecules DM350-P and DM300 outperform natural cannabinoids, steroid and immune suppressant positive controls in a mouse Colitis and rat Crohn’s model. The data presented will highlight the significant impact of medicinal chemistry on cannabinoid pharmacology, demonstrating…55
Demeetra Cas-CLOVER Research Selected as a MDPI Journal Editor’s Choice Article
Demeetra Cas-CLOVER Research Selected as a MDPI Journal Editor’s Choice Article Lexington, KY and Bloomington, IN: A pioneering study, authored by scientists from Demeetra and Indiana University, has been selected for the MDPI Journals Editor’s Choice Articles, highlighting the impact of advanced gene editing in synthetic biology to produce biopesticides. Published in Fermentation in 2023, Generation…55
BioProcess International US West 2024
Demeetra Was Proud to Present at BioProcess International West 2024 Meet our team for an introduction to our CRISPR alternative, Cas-CLOVER™. You can also catch us at our poster “piggyBac Transposase and Cas-CLOVER Targeted Nuclease Enable Rapid Discovery of Novel Hot Spots in HEK293 Suspension Cells“ March 11-14, 2024 Town and Country Resort, San Diego,…55
23rd Annual PepTalk - The Protein Science and Production Week
Proud to Attend 23rd Annual PepTalk PepTalk provides a comprehensive program and innovative solutions in antibody development, biologics characterization, and expression platforms. January 16-19, 2024 Hilton San Diego Bayfront – San Diego, CA Conference Info Meet with Demeetra! Gianguido Coffa will be attending PepTalk on January 16-17. While attending, he would love to meet in…55
The 31st Annual Plant & Animal Genome Conference 2024
Proud to Attend the 31st Plant & Animal Genome Conference PAG31 is the premier and largest Ag genomics meeting in the world. Meet us there to learn how our gene editing tools, Cas-CLOVER nuclease and piggyBac transposase, can enable research and commercial product development. Conference Info Meet with Demeetra! Gianguido Coffa will be attending PAG31.…55
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
Dublin, Ireland and Kentucky, USA, September 12: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Demeetra AgBio (‘Demeetra’). This is a non-exclusive licensing agreement granting Demeetra access to the ERS CRISPR/Cas9 patent portfolio which is sublicensable when combined with Cas-CLOVER.55
Meet Demeetra & Hera At The 2023 Industrializing Cultivated Meats & Seafood Summit
The Industrializing Cultivated Meats & Seafood Summit is your one-stop-shop for optimizing products through precise and clean gene editing and progressing your products to shelves and tabletops across the globe.
Novel Cell Line Engineering & Development Summit 2023
Sanofi’s Tiffany McLamarrah presented “Capitalizing on the Power of Next Generation Gene Editing Using Cas-CLOVER” at 10:00 am on Conference Day 2. This presentation underscores the growing recognition of Cas-CLOVER’s transformative potential in advanced gene editing applications. Sanofi’s adoption and thorough evaluation of Cas-CLOVER provide critical external validation for the platform, particularly in the cell…